New treatments

More men in Switzerland are turning to testosterone replacement therapy

Photo of man in the gym lifting weights.

This content was published on Jul 31, 2026 The testosterone replacement therapy (TRT) trend has also reached Switzerland.

New treatments

Middle-aged Swiss men are chasing testosterone. Doctors aren’t sold.

This content was published on Jul 28, 2026 Widely prescribed in the US, demand for testosterone replacement therapy (TRT) is rising in Switzerland, putting pressure on doctors to get a complex diagnosis right.

New treatments

‘A wild west’: how one Swiss company aims to tame the botox boom

This content was published on Jul 22, 2026 Galderma, headquartered in canton Zug, is training thousands of doctors to administer jabs as the risk of botched procedures rises.

Novartis acquires a British laboratory at the preclinical stage

New treatments

Novartis acquires British start-up Myricx Bio

This content was published on Jul 6, 2026 The Swiss pharma giant will pay $1.1 billion (CHF883 million) to acquire Myricx Bio, which is developing antibody-drug conjugates for various types of solid tumours.

New treatments

How a Swiss lab is finding new cures in old drugs

This content was published on Jul 6, 2026 Geneva researchers are repurposing existing drugs for rare diseases, offering new hope where options are scarce.

Roche claims clinical success for a cancer drug

New treatments

Roche claims clinical trial success for lung cancer drug

This content was published on Jul 2, 2026 Swiss pharmaceutical and diagnostics giant Roche announced the success of a pivotal clinical trial for its drug divarasib in the treatment of a form of lung cancer.

New treatments

A mother’s quest to find a cure for her son

This content was published on Jun 30, 2026 The story of how one mother is uniting families and researchers around the world to find a cure for her son's rare disease.

Swiss benchmark index SMI climbs to an all-time high

Workplace

Swiss benchmark index SMI climbs to all-time high

This content was published on Jun 25, 2026 Swiss blue-chips drove the SMI to a record high despite tech caution, global uncertainty and uneven European markets.

Trump holds up executive order in favour of research and access to psychedelic treatments for mental health in the White House's Oval office.

New treatments

Good news for Switzerland: US is fast-tracking psychedelics for mental health

This content was published on May 11, 2026 Switzerland is the only country in Europe offering psychedelic treatments, but access remains extremely limited for patients. US support means things could change. An analysis by Swissinfo.

Novartis opens seventh plant in the United States

New treatments

Swiss pharma firm Novartis plans seventh US plant

This content was published on Apr 30, 2026 Novartis is expanding its production capacity in the United States, with the announcement of a new site in Morrisville, North Carolina. This plant will bring to seven the number of new sites planned as part of its $23 billion investment plan.

New treatments

Popular Stories

Most Discussed

Sign in and personalize Swissinfo